์ด๋ฉํผํ ์ธ
์ด๋ฉํผํ ์ธ์ ์ฃผ๋ก ๋ฐ๋ ค๊ฒฌ์ ํน๋ฐ์ฑ ๊ฐ์ง ๊ด๋ฆฌ ๋ฐ ์์ ๊ณตํฌ์ฆ ์น๋ฃ์ ์ฌ์ฉ๋๋ ์ค์ถ ์์ฉ ํญ๊ฒฝ๋ จ์ ์ ๋๋ค. ํ๋ ธ๋ฐ๋ฅด๋นํ๊ณผ ๊ฐ์ ๊ธฐ์กด ํญ๊ฒฝ๋ จ์ ์ ๋ฌ๋ฆฌ ๊ฐ๋ ์ฑ ์ํ์ด ๋ฎ์ผ๋ฉฐ ์ผ๋ฐ์ ์ผ๋ก ๊ฐ ํจ์๋ฅผ ํฌ๊ฒ ์ ๋ํ์ง ์์ต๋๋ค. **์์ ํ:** ์ด๋ฉํผํ ์ธ์ ๋ถ์์ฉ์ด ์ ์ด ๊ฒฝ์ฆ์์ ์ค๋ฑ๋์ ํน๋ฐ์ฑ ๊ฐ์ง์ ์๋ ๊ฐ์๊ฒ ์ ํธ๋๋ ๊ฒฝ์ฐ๊ฐ ๋ง์ง๋ง, ์ค์ฆ ๋๋ ๊ตฐ๋ฐ์ฑ ๋ฐ์์ ๊ฒฝ์ฐ ๋จ๋ ์๋ฒ์ผ๋ก๋ ๋ถ์ถฉ๋ถํ ์ ์์ต๋๋ค.
์์ฉ ๊ธฐ์ : Imepitoin inhibits seizures via potentiation of the **GABA_A** receptor-mediated inhibitory effects on the neurons. It acts as a low-affinity partial agonist at the benzodiazepine site of the GABA_A receptor โ hyperpolarization of the neuronal membrane โ decreased neuronal excitability. Imepitoin also has a weak **calcium-channel blocking effect**, which may contribute to its anticonvulsive properties.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Severely impaired hepatic function
- Severe renal disorders
- Severe cardiovascular disorders
- Status epilepticus
- Cluster seizures (as primary monotherapy)
์ด์๋ฐ์
- Polyphagia
- Hyperactivity
- Polyuria
- Polydipsia
- Somnolence
- Hypersalivation
- Emesis
- Ataxia
์ฝ๋ฌผ ์ํธ์์ฉ
- Phenobarbital ยท May have additive CNS depressant effects ยท moderate
- Other CNS depressants ยท Additive sedation and CNS depression ยท moderate
๋ชจ๋ํฐ๋ง
- Seizure frequency and severity
- Routine blood work (CBC, serum biochemistry) periodically
๊ณผ์ฉ๋
Overdosage is generally well tolerated up to 5 times the recommended dose. Clinical signs of overdose may include severe **ataxia**, **somnolence**, **salivation**, and **vomiting**. **Clinical Pearl:** Treatment is largely supportive and symptomatic, as there is no specific antidote. Due to its rapid elimination, signs usually resolve quickly once the drug is discontinued or metabolized.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.